Reactions to mosquito bites are immunological in nature, with the involvement of IgE-, IgG- and T lymphocyte-mediated hypersensitivities. Acquired desensitization to mosquito saliva may occur during childhood and adolescence or during long-term exposure to mosquito bites. Due to the lack of salivary preparations, allergic reactions to mosquito bites are underdiagnosed and undertreated. Recombinant mosquito saliva allergens with biological activity are being developed. These recombinant allergens will significantly improve diagnosis of mosquito allergy and eventually will also improve specific immunotherapy for patients with systemic reactions to mosquito bites.

Keywords:
Mosquito allergy, Recombinant salivary allergene, IgE
1.
Simons F, Peng Z: Mosquito allergy; in Levine M, Lockey R (ed): American Academy of Allergy, Asthma and Immunology Insect Allergy Monograph. Am Academy of Allergy, Asthma and Immunology, Milwaukee, Wisc., 2003, pp 175–203.
2.
Peng Z, Yang M, Simons FER: Immunologic mechanisms in mosquito allergy: Correlation of skin reactions with specific IgE and IgG antibodies and lymphocyte proliferation response to mosquito antigens. Ann Allergy Asthma Immunol 1996;77:238–244.
3.
Peng Z, Simons FER: A prospective study of naturally acquired sensitization and subsequent desensitization to mosquito bites and concurrent antibody responses. J Allergy Clin Immunol 1998;101:284–286.
4.
Walker GB, Harrison PV: Seasonal bullous eruption due to mosquitoes. Clin Exp Dermatol 1985;10:127–132.
5.
Simons FER, Peng Z: Skeeter syndrome. J Allergy Clin Immunol 1999;104:705–707.
6.
Benaim-Pinto C, Fassrainer A: Intradermal immunotherapy in children with severe skin inflammatory reactions to Aedes aegypti and Culex quinquefasciatus mosquito bites (letter). Int J Dermatol 1990;29:600–601.
7.
Engler RJ: Mosquito bite pathogenesis in necrotic skin reactors. Curr Opin Allergy Clin Immunol 2001;1:349–352.
8.
Gluck JC, Pacin MP: Asthma from mosquito bites: A case report. Ann Allergy 1986;56:492–493.
9.
Reunala T, Brummer-Korvenkontio H, Palosuo T: Are we really allergic to mosquito bites? Ann Med 1994;26:301–306.
10.
McCormack DR, Salata KF, Hershey JN, Carpenter GB, Engler RJ: Mosquito bite anaphylaxis: Immunotherapy with whole body extracts. Ann Allergy Asthma Immunol 1995;74:39–44.
11.
Sabbah A, Hassoun S, Drouet M, Lauret MG, Doucet M: The wasp/mosquito syndrome. Allerg Immunol (Paris) 1999;31:175–184.
12.
Beckett A, Simons F, Peng Z: Mosquito bite-induced systemic reactions: Analysis of saliva specific-IgE and -IgG antibodies to 5 species in 14 individuals. J Allergy Clin Immunol 2003;111:S334.
13.
Peng Z, Ho M, Ye C, Li C, Simons E: Evidence for natural desensitization to mosquito salivary allergens – Mosquito saliva-specific IgE and IgG levels in 424 infants, children, and adolescents. J Allergy Clin Immunol 2002;109:S207.
14.
Penneys NS, Nayar JK, Bernstein H, Knight JW: Chronic pruritic eruption in patients with acquired immunodeficiency syndrome associated with increased antibody titers to mosquito salivary gland antigens. J Am Acad Dermatol 1989;21:421–425.
15.
Satoh M, Oyama N, Akiba H, Ohtsuka M, Iwatsuki K, Kaneko F: Hypersensitivity to mosquito bites with natural-killer cell lymphocytosis: The possible implication of Epstein-Barr virus reactivation. Eur J Dermatol 2002;12:381–384.
16.
Mellanby K: Man’s reaction to mosquito bites. Nature 1946;158:554.
17.
Oka K: Correlation of Aedes albopictus bite reaction with IgE antibody assay and lymphocyte transformation test to mosquito salivary antigens. J Dermatol 1989;16:341–347.
18.
Suzuki S, Negishi K, Tomizawa S, Shibasaki M, Kuroume T: A case of mosquito allergy. Immunological studies. Acta Allergol 1976;31:428–441.
19.
Reunala T, Brummer-Korvenkontio H, Rasanen L, François G, Palosuo T: Passive transfer of cutaneous mosquito-bite hypersensitivity by IgE anti-saliva antibodies. J Allergy Clin Immunol 1994;94:902–906.
20.
Brummer-Korvenkontio H, Palosuo K, Palosuo T, Brummer-Korvenkontio M, Leinikki P, Reunala T: Detection of mosquito saliva-specific IgE antibodies by capture ELISA. Allergy 1997;52:342–345.
21.
Peng Z, Beckett AN, Wang Q, Simons FER: A comparison of the UniCap test with an ELISA in the diagnosis of individuals with systemic or severe local reactions to mosquito bites. J Allergy Clin Immunol 2003;111:S207.
22.
Peng Z, Li H, Simons FER: Immunoblot analysis of salivary allergens in 10 mosquito species with worldwide distributions and the human IgE responses to these allergens. J Allergy Clin Immunol 1998;101:498–505.
23.
Brummer-Korvenkontio H, Lappalainen P, Reunala T, Palosuo T: Detection of mosquito saliva-specific IgE and IgG4 antibodies by immunoblotting. J Allergy Clin Immunol 1994;93:551–555.
24.
Solley GO, Gleich GJ, Jordon RE, Schroeter AL: The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest 1976;58:408–420.
25.
Brown A, Griffitts THD, Erwin S, Dyrenforth LY: Arthus’s phenomenon from mosquito bites. S Med J 1938;31:590–596.
26.
Suenaga Y: Mosquito bites: Especially on mosquito hypersensitivity and malignant histiocytosis. Nishinihon Hifuka Nishinihon J Dermatol 1987;49:252–259.
27.
Allen JR: Passive transfer between experimental animals of hypersensitivity to Aedes aegypti bites. Exp Parasitol 1966;19:132–137.
28.
McKiel JA, West AS: Nature and causation of insect bite reactions. Pediatr Clin North Am 1961;8:795–816.
29.
Peng Z, Rasic N, Liu Y, Simons FER: A survey of mosquito allergy by measuring serum saliva-specific IgE and IgG antibodies in 1,059 blood donors. J Allergy Clin Immunol 2002;110:816–817.
30.
Peng Z, Simons FER: Comparison of proteins, IgE, and IgG binding antigens, and skin reactivity in commercial and laboratory-made mosquito extracts. Ann Allergy Asthma Immunol 1996;77:371–376.
31.
Hudson A, Bowman L, Orr CWM: Effects of absence of saliva on blood feeding by mosquitoes. Science 1960;131:1730–1731.
32.
Ribeiro J: Role of arthropod saliva in blood feeding. Annu Rev Entomol 1987;32:463–478.
33.
Ribeiro JM: Blood-feeding arthropods: Live syringes or invertebrate pharmacologists? Infect Agents Dis 1995;4:143–152.
34.
Valenzuela JG, Belkaid Y, Garfield MK, Mendez S, Kamhawi S, Rowton ED, Sacks DL, Ribeiro JM: Toward a defined anti-Leishmania vaccine targeting vector antigens: Characterization of a protective salivary protein. J Exp Med 2001;194:331–342.
35.
Brennan JD, Kent M, Dhar R, Fujioka H, Kumar N: Anopheles gambiae salivary gland proteins as putative targets for blocking transmission of malaria parasites. Proc Natl Acad Sci USA 2000;97:13859–13864.
36.
Edwards JF, Higgs S, Beaty BJ: Mosquito feeding-induced enhancement of Cache Valley Virus (Bunyaviridae) infection in mice. J Med Entomol 1998;35:261–265.
37.
Marinotti O, James AA: An alpha-glucosidase in the salivary glands of the vector mosquito, Aedes aegypti. Insect Biochem 1990;20:619–623.
38.
Grossman GL, James AA: The salivary glands of the vector mosquito, Aedes aegypti, express a novel member of the amylase gene family. Insect Mol Biol 1993;1:223–232.
39.
Rossignol PA, Lueders AM: Bacteriolytic factor in the salivary glands of Aedes aegypti. Comp Biochem Physiol 1986;83:819–822.
40.
Owhashi M, Harada M, Suguri S, Ohmae H, Ishii A: The role of saliva of Anopheles stephensi in inflammatory response: Identification of a high molecular weight neutrophil chemotactic factor. Parasitol Res 2001;87:376–382.
41.
Nuttall PA, Paesen GC, Lawrie CH, Wang H: Vector-host interactions in disease transmission. J Mol Microbiol Biotechnol 2000;2:381–386.
42.
Charlab R, Valenzuela JG, Andersen J, Ribeiro JM: The invertebrate growth factor/CECR1 subfamily of adenosine deaminase proteins. Gene 2001;267:13–22.
43.
Isawa H, Yuda M, Orito Y, Chinzei Y: A mosquito salivary protein inhibits activation of the plasma contact system by binding to factor XII and high molecular weight kininogen. J Biol Chem 2002;277:27651–27658.
44.
Cross ML, Cupp EW, Enriquez FJ: Differential modulation of murine cellular immune responses by salivary gland extract of Aedes aegypti. Am J Trop Med Hyg 1994;51:690–696.
45.
Malafronte Rdos S, Calvo E, James AA, Marinotti O: The major salivary gland antigens of Culex quinquefasciatus are D7-related proteins. Insect Biochem Mol Biol 2003;33:63–71.
46.
Jeon SH, Park JW, Lee BH: Characterization of human IgE and mouse IgG1 responses to allergens in three mosquito species by immunoblotting and ELISA. Int Arch Allergy Immunol 2001;126:206–212.
47.
Peng Z, Li H, Simons FER: Immunoblot analysis of salivary allergens in 10 mosquito species with worldwide distribution and the human IgE responses to these allergens. J Allergy Clin Immunol 1998;101:498–505.
48.
Valenzuela JG, Pham VM, Garfield MK, Francischetti IM, Ribeiro JM: Toward a description of the sialome of the adult female mosquito Aedes aegypti. Insect Biochem Mol Biol 2002;32:1101–1122.
49.
Racioppi JV, Spielman A: Secretory proteins from the salivary glands of adult Aedes aegypti mosquitoes. Insect Biochem 1987;17:503–511.
50.
James AA: Molecular and biochemical analyses of the salivary glands of vector mosquitoes. Bull Inst Pasteur 1994;92:133–150.
51.
Valenzuela JG, Francischetti IM, Pham VM, Garfield MK, Ribeiro JM: Exploring the salivary gland transcriptome and proteome of the Anopheles stephensi mosquito. Insect Biochem Mol Biol 2003;33:717–732.
52.
Francischetti IM, Valenzuela JG, Pham VM, Garfield MK, Ribeiro JM: Toward a catalog for the transcripts and proteins (sialome) from the salivary gland of the malaria vector Anopheles gambiae. J Exp Biol 2002;205:2429–2451.
53.
Penneys NS, Nayar JK, Bernstein H, Knight JW, Leonardi C: Mosquito salivary gland antigens identified by circulating human antibodies. Arch Dermatol 1989;125:219–222.
54.
Shan EZ, Taniguchi Y, Shimizu M, Ando K, Chinzei Y, Suto C, Ohtaki T, Ohtaki N: Immunoglobulins specific to mosquito salivary gland proteins in the sera of persons with common or hypersensitive reactions to mosquito bites. J Dermatol 1995;22:411–418.
55.
Brummer-Korvenkontio H, Palosuo T, François G, Reunala T: Characterization of Aedes communis, Aedes aegypti and Anopheles stephensi mosquito saliva antigens by immunoblotting. Int Arch Allergy Immunol 1997;112:169–174.
56.
Panzani RC, Ariano R: Arthropods and invertebrates allergy (with the exclusion of mites): The concept of panallergy. Allergy 2001;56(suppl 69):1–22.
57.
Baldo BA, Panzani RC: Detection of IgE antibodies to a wide range of insect species in subjects with suspected inhalant allergies to insects. Int Arch Allergy Appl Immunol 1988;85:278–287.
58.
Eriksson NE, Ryden B, Jonsson P: Hypersensitivity to larvae of chironomids (non-biting midges). Cross-sensitization with crustaceans. Allergy 1989;44:305–313.
59.
Galindo PA, Lombardero M, Mur P, Feo F, Gomez E, Borja J, Garcia R, Barber D: Patterns of immunoglobulin E sensitization to chironomids in exposed and unexposed subjects. J Investig Allergol Clin Immunol 1999;9:117–122.
60.
Boorman J: Induction of salivation in biting midges and mosquitoes, and demonstration of virus in the saliva of infected insects. Med Vet Entomol 1987;1:211–214.
61.
Valenta R: Recombinant allergen-based concepts for diagnosis and therapy of type I allergy. Allergy 2002;57(suppl 71):66–67.
62.
Peng Z, Simons FE: Cross-reactivity of skin and serum specific IgE responses and allergen analysis for three mosquito species with worldwide distribution. J Allergy Clin Immunol 1997;100:192–198.
63.
Peng Z, Lam H, Xu W, Cheng L, Chen YL, Simons FER: Characterization and clinical relevance of two recombinant mosquito Aedes aegypti salivary allergens, rAed a 1 and rAed a 2. J Allergy Clin Immunol 1998;101:S32.
64.
Xu W, Peng Z, Simons FER: Isolation of a cDNA encoding a 30 kDa IgE-binding protein of mosquito Aedes aegypti saliva. J Allergy Clin Immunol 1998;101:S203.
65.
Xu W, Simons FER, Peng Z: Expression and rapid purification of an Aedes aegypti salivary allergen by a baculovirus system. Int Arch Allergy Immunol 1998;115:245–251.
66.
Simons FER, Peng Z: Mosquito allergy: Recombinant mosquito salivary allergens for new diagnostic tests. Int Arch Allergy Immunol 2001;124:403–405.
67.
Peng Z, Xu W, James AA, Lam H, Sun D, Cheng L, Simons FER: Expression, purification, characterization, and clinical relevance of rAed a 1 – a 68 kDa recombinant mosquito Aedes aegypti salivary allergen. Int Immunol 2001;13:1445–1452.
68.
Li C, Beckett AN, James AA, Simons FER, Arthur G, Peng Z: Diagnosis of mosquito allergy: Role of a new 67 kDa recombinant Aedes aegypti salivary allergen rAed a 4. Allergy Clin Immunol Int J World Allergy Org 2003(suppl 1):195.
69.
Larsen JN, Lowenstein H: Allergen nomenclature. J Allergy Clin Immunol 1996;97:577–578.
70.
Ribeiro JM, Sarkis JJ, Rossignol PA, Spielman A: Salivary apyrase of Aedes aegypti: Characterization and secretory fate. Comp Biochem Physiol B 1984;79:81–86.
71.
James AA, Blackmer K, Marinotti O, Ghosn CR, Racioppi JV: Isolation and characterization of the gene expressing the major salivary gland protein of the female mosquito, Aedes aegypti. Mol Biochem Parasitol 1991;44:245–253.
72.
Valenzuela JG, Charlab R, Gonzalez EC, de Miranda-Santos IK, Marinotti O, Francischetti IM, Ribeiro JM: The D7 family of salivary proteins in blood sucking diptera. Insect Mol Biol 2002;11:149–155.
73.
James AA, Blackmer K, Racioppi JV: A salivary gland-specific, maltase-like gene of the vector mosquito, Aedes aegypti. Gene 1989;75:73–83.
74.
Soldatova LN, Crameri R, Gmachl M, Kemeny DM, Schmidt M, Weber M, Mueller UR: Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia coli. J Allergy Clin Immunol 1998;101:691–698.
75.
Vailes LD, Sun AW, Ichikawa K, Wu Z, Sulahian TH, Chapman MD, Guyre PM: High-level expression of immunoreactive recombinant cat allergen (Fel d 1): Targeting to antigen-presenting cells. J Allergy Clin Immunol 2002;110:757–762.
76.
Schmidt M, McConnell TJ, Hoffman DR: Immunologic characterization of the recombinant fire ant venom allergen Sol i 3. Allergy 2003;58:342–349.
77.
Sowka S, Hsieh LS, Krebitz M, Akasawa A, Martin BM, Starrett D, Peterbauer CK, Scheiner O, Breiteneder H: Identification and cloning of prs a 1, a 32-kDa endochitinase and major allergen of avocado, and its expression in the yeast Pichia pastoris. J Biol Chem 1998;273:28091–28097.
78.
Pandjaitan B, Swoboda I, Brandejsky-Pichler F, Rumpold H, Valenta R, Spitzauer S: Escherichia coli expression and purification of recombinant dog albumin, a cross-reactive animal allergen. J Allergy Clin Immunol 2000;105:279–285.
79.
Scheurer S, Pastorello EA, Wangorsch A, Kastner M, Haustein D, Vieths S: Recombinant allergens Pru av 1 and Pru av 4 and a newly identified lipid transfer protein in the in vitro diagnosis of cherry allergy. J Allergy Clin Immunol 2001;107:724–731.
80.
Swoboda I, Bugajska-Schretter A, Verdino P, Keller W, Sperr WR, Valent P, Valenta R, Spitzauer S: Recombinant carp parvalbumin, the major cross-reactive fish allergen: A tool for diagnosis and therapy of fish allergy. J Immunol 2002;168:4576–4584.
81.
Sun D, McNicol A, Peng Z: A new platelet aggregation inhibitor – Recombinant mosquito salivary apyrase (abstract). 17th World Congress of the International Society for Heart Research, Winnipeg, 2001, p 125.
82.
Beckett AN, Sun W, Simons FER, Ma Y, Peng Z: Role of recombinant mosquito salivary allergens in the diagnosis of individuals with allergic reactions to mosquito bites. J Allergy Clin Immunol, in press.
83.
Wang H, Mao X, Simons FER, Peng Z: Induction of IgE responses using a recombinant mosquito salivary allergen rAed a 2 without adjuvant in mice. Int Arch Allergy Immunol 1999;120:135–140.
84.
Mao XJ, Wang HS, Simons FER, Peng Z: Effect of CpG oligodeoxynucleotide vaccination on ongoing IgE responses to rAed a 2 in mice. J Allergy Clin Immunol 2000;105:S112.
85.
Peng Z, Wang H, Mao X, HayGlass KT, Simons FER: CpG oligodeoxynucleotide vaccination suppresses IgE induction but may fail to down-regulate ongoing IgE responses in mice. Int Immunol 2001;13:3–11.
86.
Marinotti O, de Brito M, Moreira CK: Apyrase and alpha-glucosidase in the salivary glands of Aedes albopictus. Comp Biochem Physiol B Biochem Mol Biol 1996;113:675–679.
87.
Champagne DE, Smartt CT, Ribeiro JM, James AA: The salivary gland-specific apyrase of the mosquito Aedes aegypti is a member of the 5′-nucleotidase family. Proc Natl Acad Sci USA 1995;92:694–698.
88.
Argentine JA, James AA: Characterization of a salivary gland-specific esterase in the vector mosquito, Aedes aegypti. Insect Biochem Mol Biol 1995;25:621–630.
89.
Stark KR, James AA: Isolation and characterization of the gene encoding a novel factor Xa-directed anticoagulant from the yellow fever mosquito, Aedes aegypti. J Biol Chem 1998;273:20802–20809.
90.
Peng Z, Yang J, Wang H, Simons FER: Production and characterization of monoclonal antibodies to two new mosquito Aedes aegypti salivary proteins. Insect Biochem Mol Biol 1999;29:909–914.
91.
Champagne DE, Ribeiro JM: Sialokinin I and II: Vasodilatory tachykinins from the yellow fever mosquito Aedes aegypti. Proc Natl Acad Sci USA 1994;91:138–142.
92.
Ribeiro JM: Characterization of a vasodilator from the salivary glands of the yellow fever mosquito Aedes aegypti. J Exp Biol 1992;165:61–71.
93.
Beerntsen BT, Champagne DE, Coleman JL, Campos YA, James AA: Characterization of the sialokinin I gene encoding the salivary vasodilator of the yellow fever mosquito, Aedes aegypti. Insect Mol Biol 1999;8:459–467.
94.
Bissonnette EY, Rossignol PA, Befus AD: Extracts of mosquito salivary gland inhibit tumour necrosis factor alpha release from mast cells. Parasite Immunol 1993;15:27–33.
95.
Kleine-Tebbe J, Galleani M, Jeep S, Pilz B, Baisch A, Kunkel G: Basophil histamine release in patients with birch pollen hypersensitivity with and without allergic symptoms to fruits. Allergy 1992;47:618–623.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.